The historical rank and industry rank for aap Implantate AG's ROE % or its related term are showing as below:
CHIX:AAQ1d'
s ROE % Range Over the Past 10 Years
Min: -76.1 Med: -25.2 Max: -19.05
Current: -27.18
During the past 13 years, aap Implantate AG's highest ROE % was -19.05%. The lowest was -76.10%. And the median was -25.20%.
CHIX:AAQ1d's ROE % is ranked worse than 76.54% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs CHIX:AAQ1d: -27.18
aap Implantate AG (CHIX:AAQ1d) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
aap Implantate AG ROE % Related Terms
aap Implantate AG ROE % Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, aap Implantate AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's ROE % distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
aap Implantate AG (CHIX:AAQ1D) has a ROE % of -35.45% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #610 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 76.5%.
Is aap Implantate AG's ROE % too high?
aap Implantate AG's current ROE % is -35.45%. Based on the distribution chart, aap Implantate AG ranks #610 out of 797 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, aap Implantate AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #610 out of 797 companies for ROE %. This places aap Implantate AG in the lower half of its industry. The industry median ROE % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current ROE % is -35.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current ROE % of -35.45%. The stock's GF Value™ is €1.78, compared to a current price of €3.15 — trading 76.7% above its estimated fair value. The current ROE % is -35.45%. aap Implantate AG's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current ROE % is -35.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €3.15 is trading 76.7% above its estimated GF Value™ of €1.78.
Key valuation signals for CHIX:AAQ1D:
ROE %: -35.45%
GF Value™: €1.78 vs. price of €3.15 (76.7% above fair value)
No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
36GF Score
Get the complete analysis for CHIX:AAQ1D
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AAQ1D has been successfully added to your 
